Tips for Pharmaceutical Manufacturing Scale-Up & Tech Transfer

Identifying early warning signs is crucial for recognizing potential failures in process robustness during scale-up. Symptoms can manifest as variations in product attributes, unexpected bioburden levels post-cleaning, or inconsistencies in…

During routine Quality Control (QC) testing of a solid dosage form, manufacturing personnel noted a higher-than-expected variability in dissolution profiles across different strengths of the same product. Specifically, samples from…

In early August, Quality Control (QC) flagged several batches of a tablet product exhibiting unexpected instability in Dissolution Profile testing across different strengths, including 5 mg, 10 mg, and 20…

Before addressing process robustness risks, it is crucial to recognize the symptoms or signals indicative of potential issues. Common observations during scale-up may include:Click to read the full article.

Monitoring for signs of process robustness issues is crucial during a scale-up operation. Symptoms may manifest in various forms, including:Click to read the full article.

Low Cpk values typically signal a process that is not performing within its expected limits. Symptoms include:Click to read the full article.

Identifying symptoms on the manufacturing floor or in the laboratory is the first step in addressing potential deviations. Symptoms can manifest in several ways, including:Click to read the full article.

Enhancing Process Robustness at Scale through Effective Deviation Management In the field of pharmaceutical manufacturing, maintaining process robustness at scale post-launch is critical to ensuring product quality and compliance with…

The first indication of suboptimal sampling plans may manifest through various observable symptoms or signals. These include:Click to read the full article.

During a routine batch production of an innovative drug delivery system, quality control (QC) analysts noticed an elevated rate of out-of-specification (OOS) results for a critical quality attribute (CQA). Specifically,…

Enhancing Process Robustness in Complex Drug Delivery Systems In the highly regulated pharmaceutical manufacturing space, the ability to ensure process robustness at scale is critical, especially for complex drug delivery…

Recognizing the early warning signs of process instability during different seasons is crucial. Common symptoms include:Click to read the full article.